FOSL2 knockdown significantly weakened the inhibitory effect of ZN444B on breast cancer cell growth and metastasis in vitro, resulting in breast cancer cells being insensitive to ZN444B treatment (Fig. 4H-J). Here, FOSL2 is linked to breast carcinoma.